Evaluation of wait times for assessment and surgical intervention according the geographic area of residence in the province of Saskatchewan, Canada

Epilepsy is a highly prevalent chronic neurological disease with more than 50 million people affected worldwide [1,2]. Prevalence rates in Canada are 5 cases/year per 1000 people[3]. The inherent unpredictability of seizure occurrence contributes to impaired physical, cognitive and emotional well-being [4]. Health-related Quality of Life (QOL) is lower in persons with epilepsy (PWE) who consistently report functional impairment in comparison to controls [5–7]. The primary goals of treatment are sustained seizure freedom with minimum treatment-associated side-effects.

0